The impact of the Covid-19 pandemic on the healthcare sector is immense and varied, with nuances by subsector and geographic region. A significant aspect of the emergency and acute care delivery system has mobilized to address the virus while healthcare services focused on non-essential and elective care have been delayed. These factors will most certainly impact the M&A landscape for the foreseeable future. The short-term impacts on M&A have been widely reported. Many healthcare deals with an imminent close are continuing to completion, albeit on an elongated timeline with potential holdback structures to accommodate virus-related uncertainty. Others, particularly transactions that were earlier in the process, have been paused or halted on a case-by-case basis. The lender community will be a significant driver of M&A activity and valuations in the long-term.
Read the full article: PE Firm: Coronavirus Forces Triage on Private Equity-Backed Healthcare Deals //
Source: https://www.themiddlemarket.com/opinion/coronavirus-forces-triage-on-private-equity-backed-healthcare-deals